ReviewApplied microbiology and biotechnology2025
The MFα signal sequence in yeast-based protein secretion: challenges and innovations'.
Review in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Production of Recombinant Hemoglobin inFoods (Basel, Switzerland) · 2026Article
- Advances in Key Genetic Elements and Strategies for High-Yield Heterologous Protein Expression inJournal of fungi (Basel, Switzerland) · 2026Review
- Enhanced secretion of thermostable phytases from Myceliophthora thermophila by Komagataella phaffii.Microbial cell factories · 2026Article
- Genomic and transcriptomic insights into Trichomonascus vanleenenianus, a xylan-degrading yeast isolated from saproxylic insect larvae.BMC genomics · 2026Article
- A combined strategy for high-efficiency expression of alkaline protease PrtA in Komagataella phaffii (syn. Pichia pastoris).Microbial cell factories · 2026Article
- Engineering small peptide secretion inFrontiers in bioengineering and biotechnology · 2026Article
- Efficient Expression of Lactone Hydrolase Cr2zen for Scalable Zearalenone Degradation inToxins · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Protein secretion in yeast is a complex, multistep process heavily reliant on signal sequences to guide recombinant proteins through the secretory pathway. Among these, the mating factor alpha (MFα) signal sequence from Saccharomyces cerevisiae has emerged as a powerful tool for enhancing the extracellular production of heterologous proteins. This review provides a comprehensive overview of the MFα signal sequence, tracing its historical development and role in advancing our understanding of protein secretion mechanisms, including co- and post-translational secretory pathways. We highlight key studies focused on optimizing the MFα signal sequence for improved secretion efficiency, leading to the development of several highly effective variants. These optimized sequences have significantly increased recombinant protein yield and quality, with notable implications for both research and industrial applications. Additionally, we explore the challenges of MFα-based secretion, including issues of missorting, incorrect processing, and aggregation in the endoplasmic reticulum (ER). We discuss emerging strategies to overcome these bottlenecks, such as fusion with alternative signal sequences and strain engineering. Finally, the review highlights current efforts to develop more robust signal peptides, and underscores the importance of continued innovation in protein secretion systems to meet the growing demand for high-quality recombinant proteins in biotechnological and therapeutic applications. KEY POINTS: • MFα remains the top choice for recombinant protein secretion in yeast • Challenges in secretion: ER aggregation, missorting, and processing errors • Mutated and hybrid signal peptides offer promising solutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.